Tumor and Ablation Margin Visibility during Cryoablation of Musculoskeletal Tumors: Comparing Intraprocedural PET/CT Images with CT-Only Images.
Tumor and Ablation Margin Visibility during Cryoablation of Musculoskeletal Tumors: Comparing Intraprocedural PET/CT Images with CT-Only Images.
复制标题
DOI:
10.1016/j.jvir.2023.03.034
复制
发表时间:
2023-08
影响因子:
2.9
通讯作者:
Shyn, Paul B.
中科院分区:
文献类型:
--
作者:
Burch, Ezra A.;Bhagavatula, Sharath K.;Malone, Fiona E.;Reichert, Ryan R.;Tuncali, Kemal;Levesque, Vincent M.;Lan, Zhou;Sticka, William T.;Shyn, Paul B.
To compare tumor and ice-ball margin visibility on intraprocedural positron emission tomography (PET)/ computed tomography (CT) and CT-only images and report technical success, local tumor progression, and adverse event rates for PET/CT-guided cryoablation procedures for musculoskeletal tumors. This Health Insurance Portability and Accountability Act (HIPAA)–compliant and institutional review board–approved retrospective study evaluated 20 PET/CT-guided cryoablation procedures performed with palliative and/or curative intent to treat 15 musculoskeletal tumors in 15 patients from 2012 to 2021. Cryoablation was performed using general anesthesia and PET/CT guidance. Procedural images were reviewed to determine the following: (a) whether the tumor borders could be fully assessed on PET/CT or CT-only images; and (b) whether tumor ice-ball margins could be fully assessed on PET/CT or CT-only images. The ability to visualize tumor borders and ice-ball margins on PET/CT images was compared with that on CT-only images. Tumor borders were fully assessable for 100% (20 of 20; 95% CI, 0.83–1) of procedures on PET/CT versus 20% (4 of 20; 95 CI, 0.057–0.44) of procedures on CT only (P < .001). The tumor ice-ball margin was fully assessable in 80% (16 of 20; 95% CI, 0.56–0.94) of procedures using PET/CT versus 5% (1 of 20; 95% CI, 0.0013–0.25) of procedures using CT only (P < .001). Primary technical success was achieved in 75% (15 of 20; 95% CI, 0.51–0.91) of procedures. There was local tumor progression in 23% (3/13; 95% CI, 0.050–0.54) of the treated tumors with at least 6 months of follow-up. There were 3 adverse events (1 Grade 3, 1 Grade 2, and 1 Grade 1). PET/CT-guided cryoablation of musculoskeletal tumors can provide superior intraprocedural visualization of the tumor and ice-ball margins compared with that provided by CT alone. Further studies are warranted to confirm the long-term efficacy and safety of this approach.
登录
查看更多内容
影响因子:
19.7
作者:
Shyn, Paul B.;Casadaban, Leigh C.;Silverman, Stuart G.
通讯作者:
Silverman, Stuart G.
影响因子:
2.9
作者:
Georgiades, Christos;Rodriguez, Ronald;Netto, George
通讯作者:
Netto, George
DOI:
10.1016/j.jvir.2009.12.403
发表时间:
2010-08
期刊:
Journal of vascular and interventional radiology : JVIR
影响因子:
--
作者:
Erinjeri JP;Clark TW
通讯作者:
Clark TW
DOI:
10.1007/s00259-021-05206-5
发表时间:
2021-02-09
影响因子:
9.1
作者:
Casadaban, Leigh C.;Catalano, Paul J.;Shyn, Paul B.
通讯作者:
Shyn, Paul B.
DOI:
10.1016/j.jvir.2010.11.027
发表时间:
2011-03-01
影响因子:
2.9
作者:
Sainani, Nisha I.;Shyn, Paul B.;Silverman, Stuart G.
通讯作者:
Silverman, Stuart G.